Live News EQUITY FLASH L impact Nov 18, 2026, 12:03 PM UTC BioLineRx Sells APHEXDA Royalty Rights for $5.6 Million BioLineRx agreed to sell APHEXDA royalty rights to Soleus Capital for $5.6 million. BLK SquawkNews Desk